Semaglutide and tirzepatide can be powerful tools for the right patient — when paired with comprehensive evaluation, lifestyle foundation, and an exit strategy. Thoughtful GLP-1 management for Washington State residents who want medical care, not a vending machine.
GLP-1 medications like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) have changed what's possible in metabolic medicine. For the right patient, they can produce meaningful weight loss, improved insulin sensitivity, reduced cardiovascular risk, and a real shift in metabolic trajectory.
But these medications are not a shortcut, and they are not for everyone. Used carelessly — without lifestyle foundation, without proper evaluation, without a long-term plan — they can produce significant muscle loss, rebound weight gain, and metabolic adaptations that make future weight management harder than it was before.
At Beacon Hormone & Wellness, GLP-1 medications are one tool among many. They are prescribed selectively, after comprehensive evaluation, and always alongside the lifestyle work that determines whether the medication produces lasting benefit or just temporary results.
GLP-1 stands for "glucagon-like peptide-1" — a hormone your body naturally produces when you eat. It plays several important roles in metabolism, and GLP-1 medications work by mimicking and amplifying what this hormone already does.
In simple terms, GLP-1 medications do four main things:
Food stays in your stomach longer, which means you feel full sooner during meals and stay full for longer afterward. The constant background hunger many people experience quiets significantly.
GLP-1 acts on appetite centers in the brain, reducing the constant pull toward food and quieting what some patients describe as "food noise" — the persistent thoughts about eating that drive overconsumption.
GLP-1 helps your body use insulin more effectively and reduces glucose spikes after meals. This is why these medications were originally developed for type 2 diabetes — the metabolic benefits are substantial.
Newer research suggests GLP-1 medications also reduce cravings and the rewarding sensations of overeating. Patients often describe a fundamental shift in their relationship with food.
Beyond weight, GLP-1 medications have demonstrated reduced cardiovascular risk in clinical trials — lower rates of heart attack, stroke, and cardiovascular death in patients with metabolic disease.
Emerging research shows reduction in systemic inflammation markers, which may explain some of the broader health benefits beyond weight and glucose control.
GLP-1 medications work best for patients whose metabolic biology is genuinely working against them — and who are ready to combine medication with the lifestyle changes that make the medication actually do its job.
The FDA-approved indication for weight management. Patients with a BMI of 30 or higher are clear candidates when other conditions are met.
Patients with a BMI of 27 or higher who also have insulin resistance, prediabetes, type 2 diabetes, hypertension, dyslipidemia, or fatty liver disease.
Many GLP-1 medications are FDA-approved for type 2 diabetes management, with weight loss as a secondary benefit. Excellent option for patients with both concerns.
Patients who have made genuine, sustained lifestyle efforts and still struggle with weight or metabolic markers. GLP-1 isn't first-line — it's for when lifestyle alone isn't sufficient.
Strength training to preserve muscle. Adequate protein intake. Sleep optimization. Stress management. The medication amplifies these efforts — it doesn't replace them.
Patients with established cardiovascular disease or high cardiovascular risk who would benefit from the demonstrated cardioprotective effects of GLP-1 therapy.
Equally important — and often unmentioned by clinics that prescribe these medications freely — is who should not be on GLP-1 therapy. We are intentionally selective.
GLP-1 medications carry an FDA black box warning for medullary thyroid carcinoma. Personal or family history of MTC or MEN 2 syndrome is an absolute contraindication.
GLP-1 medications can increase pancreatitis risk. A personal history of pancreatitis is generally a contraindication, particularly if the cause was unclear or recurrent.
GLP-1 medications slow gastric emptying — which is exactly what gastroparesis already does. Pre-existing severe gastroparesis is a contraindication.
GLP-1 medications are not recommended during pregnancy. Women planning pregnancy should discontinue at least 2 months before conception to allow medication clearance.
Patients with active or recent history of eating disorders (anorexia, bulimia, binge eating disorder) should not be on GLP-1 therapy without specialty mental health support and careful coordination.
BMI under 25 with no metabolic indication is not appropriate for GLP-1 therapy. The risks of muscle and bone loss outweigh any cosmetic weight benefit.
Advanced renal or hepatic disease may require alternative approaches. We evaluate organ function before prescribing.
If GLP-1 is being sought purely for cosmetic weight loss without metabolic indication or commitment to lifestyle change, we are not the right practice. There are clinics that prescribe more freely; we are not one of them.
Patients who are not willing to address protein intake, strength training, sleep, and stress will not get the benefit GLP-1s can provide — and may experience the worst of the side effects with the least of the rewards.
Side effects are real and common with GLP-1 therapy. Most are gastrointestinal, dose-dependent, and improve over time as your body adjusts. Honest discussion of what to expect is part of every initial visit.
Most common (often improve with time):
Less common but more concerning:
Slow Titration
We start at the lowest dose and increase slowly — slower than some clinics — to minimize side effects and maximize tolerability.
Hold or Step Back When Needed
If side effects are significant, we hold the dose or step back to a lower dose rather than pushing through. The goal is sustainability, not the fastest possible titration.
Active Monitoring
Lab monitoring, body composition tracking when appropriate, and regular check-ins to catch issues early — not after they become problems.
Discontinuation Plan
If GLP-1 therapy isn't working or side effects are intolerable, we have an honest conversation about alternatives rather than pushing the medication indefinitely.
You may have heard about compounded GLP-1 medications offered at lower cost than brand-name versions. Here's our honest stance on this:
FDA-Approved (Preferred When Feasible):
Wegovy (semaglutide), Zepbound (tirzepatide), Saxenda (liraglutide), and Mounjaro/Ozempic for diabetes indications are our first-line preference. These have known purity, consistent dosing, and full clinical trial backing.
Compounded (Available With Patient Understanding):
Compounded semaglutide and tirzepatide can be appropriate when FDA-approved versions are inaccessible due to cost or shortage — but only from reputable, well-vetted compounding pharmacies. We discuss the trade-offs honestly: lower cost, but less regulatory oversight, variable quality across compounders, and potential for differences in absorption or potency.
Patient-Decided, With Clinical Guidance:
The choice between FDA-approved and compounded GLP-1 is a real decision with real trade-offs. We give you the information needed to choose what fits your situation, your budget, and your comfort level — without pressure in either direction.
What we will not do:
GLP-1 medications work best — and produce the most lasting benefit — when paired with the lifestyle foundation that determines whether weight loss is durable or temporary. We don't treat lifestyle as an afterthought.
1.2 to 2.0 grams of protein per kilogram of body weight per day. Without sufficient protein, weight lost on GLP-1 includes substantial muscle — which makes future weight regain more likely and reduces metabolic rate.
Resistance training 2-4 times per week to preserve and build muscle. This is non-negotiable for sustainable results. Cardio alone is not sufficient.
7-9 hours of quality sleep. Sleep deprivation undermines weight loss, increases hunger hormones, and impairs the metabolic benefits of GLP-1 therapy.
Chronic stress drives cortisol, which works against the metabolic benefits of GLP-1 therapy. We address this as part of the treatment plan.
GLP-1 medications can cause dehydration, particularly with reduced intake. Hydration targets are part of every treatment plan.
What does life after GLP-1 look like? Are you on it indefinitely, or is there a plan to taper? These questions get answered upfront, not when you're already on the medication.
Thoughtful GLP-1 management is rare in telemedicine. Many telehealth weight loss clinics operate as high-volume prescription mills with minimal evaluation, no lifestyle integration, and no plan beyond ongoing prescription refills. We offer something different — for Washington State residents who want medical care, not just access to medication.
Our telemedicine practice serves patients across Washington — from the upper Kittitas County communities of Cle Elum, Roslyn, and the Suncadia Resort area, to the I-90 corridor through North Bend and Snoqualmie, to the wine country and mountain towns of Leavenworth and Chelan. Eastside Seattle residents in Mercer Island, Redmond, Kirkland, Sammamish, Issaquah, and Woodinville often choose telemedicine for the comprehensive evaluation that brief in-person visits can't provide. Island residents on Bainbridge, Vashon, and in the San Juan Islands around Friday Harbor, along with Kitsap Peninsula communities including Poulsbo and Gig Harbor, and Southwest Washington residents in Camas and Ridgefield, all receive the same comprehensive care via secure video.
Lab work is coordinated at Quest Diagnostics locations near you. Prescriptions are sent to your preferred pharmacy or compounding pharmacy when applicable.
The initial consultation includes comprehensive evaluation, honest assessment of whether GLP-1 therapy is appropriate for you, and a treatment plan that integrates medication with lifestyle if we move forward. Available to Washington State residents.
Book Initial Consult — $175 Learn About the Metabolic Reset →Related Services
Learn more about metabolic health and insulin resistance, our structured 12-Week Metabolic Reset Program, lifestyle medicine, and preventive medicine. For men's hormone concerns, see men's hormone therapy. For women's hormone care, see women's hormone therapy.